Article
EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non–small cell lung cancer
30 May 2024
Abstract excerpt
The transformation of lung adenocarcinoma to small cell lung cancer (SCLC) is a recognized resistance mechanism and a hindrance to therapies using epidermal growth factor receptor tyrosine kinase inhibitors (TKIs). The paucity of pretranslational/posttranslational clinical samples limits the deeper understanding of resistance mechanisms and the exploration of effective therapeutic strategies. Here, we developed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
